patients assigned to the terazosin hydrochloride treatment group received increasing dosages ( 1,2,5 , and 10 mg daily ) [ corrected ] of terazosin at two-week intervals until the maximum dose was reached or until the supine dbp was decreased to less than 90 mm hg .
C0770137
terazosin hydrochloride
C0076107
terazosin